This report contains market size and forecasts of Anamorelin in global, including the following market information:
Global Anamorelin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Anamorelin Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Anamorelin companies in 2021 (%)
The global Anamorelin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity ≥98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anamorelin include Chengdu Climb Pharmaceutical, Chengda Pharmaceuticals, Hunan Huateng Pharmaceutical, JieJie Group, Helsinn and AlchemyPharm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anamorelin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anamorelin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Anamorelin Market Segment Percentages, by Type, 2021 (%)
Purity ≥98%
Purity ≥99%
Global Anamorelin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Anamorelin Market Segment Percentages, by Application, 2021 (%)
Anorexia Treatment
Medical Research (Oncology)
Other
Global Anamorelin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Anamorelin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anamorelin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Anamorelin revenues share in global market, 2021 (%)
Key companies Anamorelin sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Anamorelin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chengdu Climb Pharmaceutical
Chengda Pharmaceuticals
Hunan Huateng Pharmaceutical
JieJie Group
Helsinn
AlchemyPharm